{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:32Z","timestamp":1789115492645,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tranon.2026.102843","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:35:37Z","timestamp":1780576537000},"page":"102843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A pan-cancer landscape of LILRB4 identifies it as a context-dependent marker of the myeloid and antigen-presentation axis"],"prefix":"10.1016","volume":"70","author":[{"given":"Jiabin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9831-4334","authenticated-orcid":false,"given":"Chaoshun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tranon.2026.102843_bib0001","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity."},{"issue":"1","key":"10.1016\/j.tranon.2026.102843_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12964-017-0168-z","article-title":"The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation","volume":"15","author":"Wolff","year":"2017","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.tranon.2026.102843_bib0003","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41408-024-01199-0","article-title":"Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed\/refractory angioimmunoblastic T-cell lymphoma","volume":"14","author":"Zhu","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2026.102843_bib0004","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41590-025-02233-4","article-title":"Secretogranin 2 binds LILRB4 resulting in immunosuppression","volume":"26","author":"Yang","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tranon.2026.102843_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70090","article-title":"Homoharringtonine promotes FTO degradation to suppress LILRB4-mediated immune evasion in acute monocytic leukaemia","volume":"59","author":"Huang","year":"2026","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.tranon.2026.102843_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151536","article-title":"LILRB4 specific overexpression in myeloid cells promotes tumor progression and immunosuppression in mouse models","volume":"755","author":"Wang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.tranon.2026.102843_bib0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/intimm\/dxac023","article-title":"Myeloid immune checkpoint ILT3\/LILRB4\/gp49B can co-tether fibronectin with integrin on macrophages","volume":"34","author":"Itoi","year":"2022","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102843_bib0008","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/intimm\/dxab028","article-title":"Blockade of checkpoint ILT3\/LILRB4\/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB\/Yaa mice","volume":"33","author":"Su","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.tranon.2026.102843_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1559301","article-title":"LILR genotype imputation with attribute bagging (LIBAG): leukocyte immunoglobulin-like receptor copy number imputation system","volume":"16","author":"Khor","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102843_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1620\/tjem.2022.J014","article-title":"Co-localization of Fibronectin Receptors LILRB4\/gp49B and Integrin on Dendritic Cell Surface","volume":"257","author":"Takahashi","year":"2022","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.tranon.2026.102843_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.110375","article-title":"SHP-1 negatively regulates LPS-induced M1 polarization, phagocytic activity, inflammation and oxidative stress in primary macrophages of Chinese tongue sole (Cynoglossussemilaevis)","volume":"163","author":"Wang","year":"2025","journal-title":"Fish. Shellfish. Immunol."},{"key":"10.1016\/j.tranon.2026.102843_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.110624","article-title":"SHP-1 regulates T cell-mediated early adaptive immunity in Chinese tongue sole (Cynoglossus semilaevis) infected with Mycobacterium marinum","volume":"166","author":"Wang","year":"2025","journal-title":"Fish. Shellfish. Immunol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102843_bib0013","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.2100266","article-title":"Non-Lyn Src family kinases activate SIRP\u03b1-SHP-1 to dampen proinflammatory macrophage polarization","volume":"207","author":"Shi","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.tranon.2026.102843_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102381","article-title":"Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma","volume":"56","author":"Wang","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102843_bib0015","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-025-60456-3","article-title":"CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRP\u03b1-CD47 to suppress tumor growth","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102843_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115131","article-title":"Vitamin D against diabetic adipose tissue inflammation through SHP-1\/STAT3 pathway","volume":"162","author":"Wei","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2026.102843_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118253","article-title":"The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia","volume":"189","author":"Sordo-Bahamonde","year":"2025","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.tranon.2026.102843_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00262-024-03880-6","article-title":"NLRP12\/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4\/NF-\u03baB pathway in lung adenocarcinoma","volume":"74","author":"Yin","year":"2024","journal-title":"Cancer Immunol. Immunther."},{"issue":"2","key":"10.1016\/j.tranon.2026.102843_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451172","article-title":"A switch protein adapter for anti-LILRB4 CAR-T Cells","volume":"55","author":"Huang","year":"2025","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102843_bib0020","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1002\/cai2.153","article-title":"Leukocyte immunoglobulin-like receptor B4: a keystone in immune modulation and therapeutic target in cancer and beyond","volume":"3","author":"Liu","year":"2024","journal-title":"Cancer Innov"},{"issue":"22","key":"10.1016\/j.tranon.2026.102843_bib0021","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1097\/CM9.0000000000003195","article-title":"Leukocyte immunoglobulin-like receptor B4 (LILRB4) in acute myeloid leukemia: from prognostic biomarker to immunotherapeutic target","volume":"137","author":"Li","year":"2024","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.tranon.2026.102843_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116762","article-title":"LILRB4 as a novel immunotherapeutic target for multiple diseases","volume":"233","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tranon.2026.102843_bib0023","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12957-022-02562-w","article-title":"Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer","volume":"20","author":"Fan","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102843_bib0024","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/2326-6066.CIR-21-0240","article-title":"The Fibronectin-ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells","volume":"9","author":"Paavola","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.tranon.2026.102843_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113706","article-title":"Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-\u03baB pathway","volume":"144","author":"Xiong","year":"2025","journal-title":"Int. Immunopharmacol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:36:59Z","timestamp":1789112219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S1936523326001804"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102843","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pan-cancer landscape of LILRB4 identifies it as a context-dependent marker of the myeloid and antigen-presentation axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102843"}}